Product DCB COROANRY OVERVIWE
Previous drug balloon clinical pain points
The coating particles are too large, and the large particles fall off during elution, resulting in distal microvascular embolism
Contrast excipients tend to cause vascular inflammation, resulting in distal microvascular embolism
Low drug absorption rate
Too many drugs are lost during balloon delivery
Hydrophilic excipients inhibit drug transfer and absorption to some extent
The drug is washed away by the blood stream to the distal end of the vessel before it can be transferred to the vessel wall
Innovative drug coating technology
DCB Balloon Advatages
realizes effective release and absorption of paclitaxel
Nanosized crystals greatly reduce the probability of distal vascular microembolism, further ensuring safety
Excipient free: safe coating
Porcine vascular tissue section 28 days after operation showed that compared with similar products, fengtai significantly reduced the inflammatory reaction and thrombosis in the proximal vessels of balloon dilated segment.
